TradingKey

关于 AxoGen Inc 公司

Axogen, Inc. 专注于周围神经再生和修复技术的科学、开发和商业化。该公司为外科医生和医疗保健提供者提供修复解决方案。其产品包括 Avance 神经移植物、Axoguard 神经连接器、Axoguard 神经保护器、Axoguard 神经帽、Axotouch 双点鉴别器和 Axoguard HA+ 神经保护器。Avance 神经移植物是一种生物活性处理的人类神经同种异体移植物，用于桥接断裂的周围神经，而不会产生与第二个手术部位相关的并发症。Axoguard 神经连接器是一种猪粘膜下层细胞外基质接合辅助剂，用于无张力修复断裂的周围神经。Axoguard 神经保护器是一种猪粘膜下层 ECM 产品，用于包裹和保护受损的周围神经并加强神经重建，同时防止软组织附着。Axotouch 双点鉴别器用于测量皮肤任何表面积的神经支配密度。

公司简介

公司代码AXGN

公司名称AxoGen Inc

上市日期Dec 17, 1986

CEOMr. Michael Donald (Mike) Dale

员工数量451

证券类型Ordinary Share

年结日Dec 17

公司地址13631 Progress Blvd.

城市ALACHUA

上市交易所NASDAQ Capital Market Consolidated

国家United States of America

邮编32615

电话13864626817

网址https://www.axogeninc.com/

公司代码AXGN

上市日期Dec 17, 1986

CEOMr. Michael Donald (Mike) Dale

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Erick Wayne Devinney

Chief Innovation Officer

150.41K

-30.16%

Mr. Paul G. Thomas

Independent Chairman of the Board

21.40K

-38.73%

Ms. Lindsey Hartley

Chief Financial Officer

20.76K

--

Mr. Jens Schroeder Kemp

Chief Marketing Officer

12.68K

-54.18%

Mr. Rick Ditto

Vice President - Global Health Economics, Reimbursement & Policy

--

Mr. John H. Johnson

Independent Director

--

Ms. Kathy Weiler

Independent Director

--

Mr. Marc A. Began

Executive Vice President, Chief Compliance Officer, General Counsel

--

Mr. William P. (Bill) Burke

Independent Director

--

Mr. Alan M. Levine

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Erick Wayne Devinney

Chief Innovation Officer

150.41K

-30.16%

Mr. Paul G. Thomas

Independent Chairman of the Board

21.40K

-38.73%

Ms. Lindsey Hartley

Chief Financial Officer

20.76K

--

Mr. Jens Schroeder Kemp

Chief Marketing Officer

12.68K

-54.18%

Mr. Rick Ditto

Vice President - Global Health Economics, Reimbursement & Policy

--

Mr. John H. Johnson

Independent Director

--

收入明细

FY2023

FY2022

暂无数据

地区USD

名称

营收

占比

United States

159.01M

0.00%

业务

地区

暂无数据

股东统计

更新时间: 5月17日周六

持股股东

股东类型

持股股东

占比

First Light Asset Management, LLC

9.82%

BlackRock Institutional Trust Company, N.A.

6.87%

The Vanguard Group, Inc.

5.55%

ArrowMark Colorado Holdings, LLC

3.49%

Morgan Stanley & Co. LLC

3.48%

Other

70.78%

持股股东

占比

First Light Asset Management, LLC

9.82%

BlackRock Institutional Trust Company, N.A.

6.87%

The Vanguard Group, Inc.

5.55%

ArrowMark Colorado Holdings, LLC

3.49%

Morgan Stanley & Co. LLC

3.48%

Other

70.78%

股东类型

持股股东

占比

Investment Advisor/Hedge Fund

38.46%

Investment Advisor

27.64%

Hedge Fund

14.22%

Research Firm

5.24%

Individual Investor

4.80%

Pension Fund

0.48%

Bank and Trust

0.32%

Sovereign Wealth Fund

0.17%

Venture Capital

0.05%

Other

8.62%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

352

41.63M

91.41%

-2.42M

2025Q1

357

42.08M

92.45%

-1.70M

2024Q4

343

39.00M

87.97%

-5.62M

2024Q3

323

39.49M

90.05%

-1.54M

2024Q2

302

38.53M

87.94%

-4.16M

2024Q1

307

37.61M

87.02%

-4.05M

2023Q4

318

35.68M

82.81%

-5.15M

2023Q3

322

35.50M

82.64%

-5.39M

2023Q2

319

36.28M

84.47%

-3.01M

2023Q1

324

35.99M

84.11%

-3.05M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

First Light Asset Management, LLC

4.47M

9.82%

-32.58K

-0.72%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.13M

6.87%

+93.19K

+3.07%

Mar 31, 2025

The Vanguard Group, Inc.

2.53M

5.55%

+103.94K

+4.28%

Mar 31, 2025

ArrowMark Colorado Holdings, LLC

1.59M

3.49%

-657.69K

-29.25%

Mar 31, 2025

Morgan Stanley & Co. LLC

1.59M

3.48%

-105.62K

-6.24%

Mar 31, 2025

Soleus Capital Management, L.P.

1.45M

3.18%

-1.51M

-51.08%

Mar 31, 2025

Driehaus Capital Management, LLC

1.17M

2.57%

+217.59K

+22.80%

Mar 31, 2025

Zaderej (Karen L)

1.14M

2.51%

+71.04K

+6.62%

Mar 21, 2024

Geode Capital Management, L.L.C.

1.03M

2.25%

+19.92K

+1.98%

Mar 31, 2025

Assenagon Asset Management S.A.

1.00M

2.2%

+174.68K

+21.13%

Mar 31, 2025

持股ETF

更新时间: 8月2日周六

机构名称

占比

ROBO Global Healthcare Technology & Innovation ETF

1.87%

SPDR S&P Health Care Equipment ETF

1.2%

iShares Neuroscience and Healthcare ETF

1.14%

Fidelity Digital Health ETF

0.89%

Invesco NASDAQ Future Gen 200 ETF

0.45%

AAM Sawgrass US Small Cap Quality Growth ETF

0.44%

Fidelity Enhanced Small Cap ETF

0.13%

Vanguard US Momentum Factor ETF

0.11%

iShares Micro-Cap ETF

0.11%

Franklin US Small Cap Multifactor Index ETF

0.07%

ROBO Global Healthcare Technology & Innovation ETF

占比1.87%

SPDR S&P Health Care Equipment ETF

占比1.2%

iShares Neuroscience and Healthcare ETF

占比1.14%

Fidelity Digital Health ETF

占比0.89%

Invesco NASDAQ Future Gen 200 ETF

占比0.45%

AAM Sawgrass US Small Cap Quality Growth ETF

占比0.44%

Fidelity Enhanced Small Cap ETF

占比0.13%

Vanguard US Momentum Factor ETF

占比0.11%

iShares Micro-Cap ETF

占比0.11%

Franklin US Small Cap Multifactor Index ETF

占比0.07%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

AxoGen Inc

12.665USD

AxoGen Inc

12.665

概览

公司

财务